Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:325362.
doi: 10.1155/2011/325362. Epub 2011 Sep 15.

Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance

Stamatis Katsenos  1 , Stavros H Constantopoulos
Affiliations

Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance

Stamatis Katsenos et al. Pulm Med. 2011.

Abstract

Long-term oxygen therapy (LTOT) is the cornerstone mode of treatment in patients with severe chronic obstructive pulmonary disease (COPD) associated with resting hypoxaemia. When appropriately prescribed and correctly used, LTOT has clearly been shown to improve survival in hypoxemic COPD patients. Adherence to LTOT ranges from 45% to 70% and utilization for more than 15 hours per day is widely accepted as efficacious. Although several studies have addressed the level of patients' adherence to LTOT, few have suggested or evaluated interventions that conduce to compliance enhancement. The lack of sufficient data regarding COPD patients following oxygen prescription is an enormous void that must be duly confronted to augment clinical effectiveness and cost containment for the long term use. The present review article highlights factors influencing the compliance of patients using LTOT and emphasizes novel strategies and interventions that may prove to be of significant benefit given the remarkably little current research appraising this issue. Therefore, additional research should be promptly performed to verify the efficacy of newly designed approaches in improving the outcomes of patients receiving LTOT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Long-term oxygen therapy: a research agenda for compliance.
See this image and copyright information in PMC

References

    1. Kvale PA, Conway WA, Coates EO. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial. Annals of Internal Medicine. 1980;93(3):391–398. - PubMed
    1. Stuart-Harris C, Bishop JM, Clark TJH. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. The Lancet. 1981;1(8222):681–686. - PubMed
    1. Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the nocturnal oxygen therapy trial revisited) Respiratory Care. 2000;45(2):204–213. - PubMed
    1. Crockett AJ, Cranston JM, Moss JR, Alpers JH. A review of long-term oxygen therapy for chronic obstructive pulmonary disease. Respiratory Medicine. 2001;95(6):437–443. - PubMed
    1. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respiratory Medicine. 2004;98(4):285–293. - PubMed

LinkOut - more resources